PHARM.AS
Price:
$0.6545
Market Cap:
$492.33M
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The com...[Read more]
Industry
Biotechnology
IPO Date
1999-06-16
Stock Exchange
EURONEXT
Ticker
PHARM.AS
According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 567.21M. This represents a change of -30.05% compared to the average of 810.86M of the last 4 quarters.
The mean historical Enterprise Value of Pharming Group N.V. over the last ten years is 514.85M. The current 567.21M Enterprise Value has changed 10.92% with respect to the historical average. Over the past ten years (40 quarters), PHARM.AS's Enterprise Value was at its highest in in the December 2019 quarter at 999.97M. The Enterprise Value was at its lowest in in the March 2016 quarter at 74.91M.
Average
514.85M
Median
562.39M
Minimum
97.14M
Maximum
965.62M
Discovering the peaks and valleys of Pharming Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.08%
Maximum Annual Enterprise Value = 965.62M
Minimum Annual Increase = -38.98%
Minimum Annual Enterprise Value = 97.14M
Year | Enterprise Value | Change |
---|---|---|
2023 | 776.13M | 9.05% |
2022 | 711.70M | 52.26% |
2021 | 467.42M | -38.98% |
2020 | 766.06M | -20.67% |
2019 | 965.62M | 98.44% |
2018 | 486.60M | -23.75% |
2017 | 638.17M | 400.61% |
2016 | 127.48M | 31.23% |
2015 | 97.14M | -13.40% |
2014 | 112.17M | 1.08% |
The current Enterprise Value of Pharming Group N.V. (PHARM.AS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
651.75M
5-year avg
737.39M
10-year avg
514.85M
Pharming Group N.V.’s Enterprise Value is less than Galapagos NV (1.60B), less than Koninklijke BAM Groep nv (781.47M), less than Fugro N.V. (2.57B), less than PostNL N.V. (1.10B), less than AMG Advanced Metallurgical Group N.V. (981.84M),
Company | Enterprise Value | Market cap |
---|---|---|
1.60B | $1.65B | |
781.47M | $929.67M | |
2.57B | $2.22B | |
1.10B | $608.06M | |
981.84M | $429.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharming Group N.V.'s Enterprise Value?
What is the highest Enterprise Value for Pharming Group N.V. (PHARM.AS)?
What is the 3-year average Enterprise Value for Pharming Group N.V. (PHARM.AS)?
What is the 5-year average Enterprise Value for Pharming Group N.V. (PHARM.AS)?
How does the current Enterprise Value for Pharming Group N.V. (PHARM.AS) compare to its historical average?